Targeting pseudotyped retroviral vectors
View Patent ↗The present invention provides targeted lentiviral vectors that are psuedotyped with mutated Sindbis envelopes. For example, mutations in the Sindbis E2 protein are used to alter viral titer, specificity, specificity index, tropism, and susceptibility to host immune response. Typically, one or more of the E1, E2, or E3 proteins can be mutated at one or more amino acid positions. The psuedotyped, targeted lentiviral vectors of the invention are used to transduce heterologous genes into a cell and can be used for in vivo and ex vivo therapeutic applications, as well as for diagnostic and research tool applications.
1. An isolated pseudotyped retrovirus comprising mutant Sindbis virus E2 and E3 proteins, wherein the mutant Sindbis virus E2 protein comprises an IgG Fc binding ZZ domain polypeptide and the sequence SLKQ of a SINDBIS virus E2 protein is replaced with the sequence AAAA and wherein the mutant Sindbis virus E3 protein comprises a deletion of the sequence RSKR of a Sindbis virus E3 protein.
2. The isolated pseudotyped retrovirus of claim 1 , further comprising a targeting moiety.
3. The isolated pseudotyped retrovirus of claim 2 , wherein the targeting moiety is an antibody directed against a tumor specific cell surface antigen.
4. The isolated pseudotyped retrovirus of claim 3 , wherein the targeting moiety is an antibody directed against p-glycoprotein.
5. The isolated pseudotyped retrovirus of claim 2 , wherein the targeting moiety is an antibody directed against a tissue specific antigen.
6. The isolated pseudotyped retrovirus of claim 5 , wherein the targeting moiety is an antibody directed against the transferrin receptor.
7. The isolated psuedotyped retrovirus of claim 1 further comprising a mutant Sindbis virus E1 protein wherein the mutant Sindbis virus E1 is the E1 protein encoded by SEQ ID NO:5.
8. The isolated psuedotyped retrovirus of claim 1 wherein the mutant E2 protein is the protein encoded by SEQ ID NO:3.